Pakistan and China concluded a pharmaceutical and healthcare conference with $850 million in agreements, including 16 contracts and 80 MoUs. These deals focus on local production of health equipment, pharmaceutical raw materials, and vaccines, with 18 agreements specifically for herbal medicines. The initiative aims to significantly reduce Pakistan's import bill, save valuable foreign exchange, and create employment opportunities. This development could support the Pakistani Rupee, potentially influencing local gold and silver prices by affecting the USD/PKR exchange rate.
بحوالہ / Source: www.dawn.com